Platinum Investment Management LTD Esperion Therapeutics, Inc. Transaction History

Platinum Investment Management LTD

$2.45 Billion
Q2 2024

A detailed history of Platinum Investment Management LTD transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,196,526 shares of ESPR stock, worth $2.01 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,196,526

Previous 1,597,542 25.1%

Holding current value

$2.01 Million

Previous $4.28 Million 37.96%

% of portfolio

0.11%

Previous 0.18%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.84 - $3.24 $737,869 - $1.3 Million	-401,016 Reduced 25.1%	1,196,526 $2.66 Million
Q1 2024 May 13, 2024	SELL	$2.02 - $3.02 $2.45 Million - $3.66 Million	-1,213,013 Reduced 43.16%	1,597,542 $4.28 Million
Q4 2023 Feb 13, 2024	SELL	$0.73 - $3.08 $276,642 - $1.17 Million	-378,962 Reduced 11.88%	2,810,555 $8.4 Million
Q3 2023 Nov 02, 2023	SELL	$0.96 - $1.79 $268,912 - $501,409	-280,117 Reduced 8.07%	3,189,517 $3.13 Million
Q2 2023 Aug 10, 2023	BUY	$1.2 - $1.76 $1.07 Million - $1.56 Million	889,059 Added 34.45%	3,469,634 $4.82 Million
Q1 2023 May 11, 2023	BUY	$1.46 - $7.3 $1.68 Million - $8.4 Million	1,150,574 Added 80.46%	2,580,575 $4.1 Million
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $1.05 Million - $1.57 Million	-193,439 Reduced 11.92%	1,430,001 $9.58 Million
Q2 2022 Aug 11, 2022	SELL	$4.77 - $6.67 $5.2 Million - $7.27 Million	-1,089,736 Reduced 40.16%	1,623,440 $10.3 Million
Q4 2021 Feb 11, 2022	BUY	$4.81 - $11.92 $4.81 Million - $11.9 Million	1,000,000 Added 58.37%	2,713,176 $13.6 Million
Q2 2021 Aug 11, 2021	BUY	$19.4 - $28.71 $2.18 Million - $3.23 Million	112,563 Added 7.03%	1,713,176 $36.2 Million
Q1 2021 May 13, 2021	BUY	$25.12 - $36.89 $948,129 - $1.39 Million	37,744 Added 2.42%	1,600,613 $44.9 Million
Q4 2020 Feb 12, 2021	BUY	$24.2 - $35.76 $16.8 Million - $24.9 Million	696,188 Added 80.33%	1,562,869 $40.6 Million
Q3 2020 Nov 13, 2020	BUY	$31.18 - $52.71 $474,809 - $802,667	15,228 Added 1.79%	866,681 $32.2 Million
Q2 2020 Aug 06, 2020	BUY	$30.04 - $51.31 $1.19 Million - $2.04 Million	39,761 Added 4.9%	851,453 $43.7 Million
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $21.2 Million - $57.1 Million	773,238 Added 2010.81%	811,692 $25.6 Million
Q4 2019 Feb 13, 2020	BUY	$35.4 - $59.82 $1.36 Million - $2.3 Million	38,454 New	38,454 $2.29 Million

Others Institutions Holding ESPR

# of Institutions

199

Shares Held

136M

Call Options Held

2.72M

Put Options Held

1.3M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $112M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Account

Platinum Investment Management LTD Esperion Therapeutics, Inc. Transaction History